Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Tranexamic Acid with or without Microneedling for Facial Erythema
NCT05897918Completed
- Sponsor
- Al-Azhar University
- Start
- Aug 2020
- Primary completion
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of tranexamic acid in facial erythema and telangiectasia, sponsored by Al-Azhar University. Primary endpoint: Change in facial erythema. Started Aug 2020; status: completed.
02
Drugs
tranexamic acid
03
Conditions
facial erythematelangiectasia
Beyond the preview
Go deeper on NCT05897918.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05897918.